Subgroup analysis of ERG-negative and ERG-positive cancers revealed that these associations were merely driven by the subset of ERG-negative cancers (Figure 4b), while there was no unequivocal impact of GGH levels on the deletion status in ERG-positive cancers (Figure 4c). The gene discussed is ERG; the disease is cancer.